Step 1 topics → Endocrine → Hypothalamic-Pituitary-Gonadal (HPG) Axis

Hypothalamic-Pituitary-Gonadal (HPG) Axis

USMLE Step 1 trap: Confuses continuous GnRH agonist administration as stimulatory rather than suppressive due to receptor downregulation. Continuous GnRH downregulates GnRH receptors on gonadotrophs, suppressing LH and FSH, while pulsatile GnRH maintains receptor sensitivity and stimulates gonadotropin release.

The HPG axis is one of the highest-yield endocrine topics on USMLE Step 1, and it shows up in more ways than students expect. At its core, it's a three-tier cascade: GnRH from the hypothalamus drives LH and FSH from the anterior pituitary, which act on the gonads to produce sex steroids and gametes. Those steroids then feed back — usually negatively — to regulate the axis. That much most students know. What trips them up is the nuance: the feedback isn't always negative, the delivery method of GnRH completely changes its effect, and prolactin disrupts the axis at the hypothalamic level, not at the gonad.

The exam tests this concept from multiple angles. Some questions are straightforward recall — where does GnRH act, what does LH do in males vs females. But the higher-yield questions are mechanistic and clinical. A vignette about a patient on leuprolide (a continuous GnRH agonist) having suppressed testosterone is testing whether you understand receptor downregulation, not just that 'leuprolide is used in prostate cancer.' A question about a woman with amenorrhea and elevated prolactin is testing whether you know the hypothalamic mechanism, not just the lab pattern. USMLE Step 1 loves to present these as passage-based vignettes where you have to reason through which level of the axis is disrupted.

The three biggest misconceptions clustered around this topic are: (1) assuming continuous GnRH agonism is as stimulatory as pulsatile, (2) assuming prolactin causes hypogonadism by acting directly on the gonad, and (3) treating estrogen feedback as uniformly negative. All three reflect applying an oversimplified model to a system that has real, testable exceptions. Nail the exceptions and you will handle every HPG axis question USMLE Step 1 throws at you.

From real student decks
54%have cards covering this topic
38%have mature cards

Common misconceptions

Common mistake
Wrong: Continuous GnRH administration stimulates LH and FSH release just as effectively as pulsatile GnRH.
Right: Continuous GnRH downregulates GnRH receptors on gonadotrophs, suppressing LH and FSH, while pulsatile GnRH maintains receptor sensitivity and stimulates gonadotropin release.
Pituitary gonadotrophs require intermittent GnRH stimulation to stay responsive — pulsatile delivery allows receptor recycling and sustained LH/FSH secretion. When GnRH is delivered continuously (or a long-acting agonist like leuprolide is used), GnRH receptors are chronically occupied and get internalized and downregulated, so the gonadotroph stops responding. This is why leuprolide, despite being a GnRH agonist, is used to suppress testosterone in prostate cancer — the initial 'flare' of LH is quickly followed by profound suppression.
Common mistake
Wrong: Hyperprolactinemia causes hypogonadism by directly inhibiting the gonads.
Right: Hyperprolactinemia inhibits hypothalamic GnRH pulsatility, which reduces LH and FSH, leading to secondary hypogonadism.
Prolactin does not have significant direct inhibitory receptors on gonadal tissue — its suppressive effect on reproduction is mediated upstream at the hypothalamus. High prolactin inhibits the kisspeptin/GnRH pulse generator, reducing GnRH pulsatility, which in turn drops LH and FSH. The result is secondary hypogonadism: low sex steroids with low or inappropriately normal gonadotropins — a lab pattern that pinpoints the defect at the hypothalamus, not the gonad.
Common mistake
Wrong: Estrogen always exerts negative feedback on LH secretion.
Right: Estrogen exerts negative feedback on LH at low levels but switches to positive feedback at high sustained levels (as seen at mid-cycle), triggering the LH surge and ovulation.
Estrogen's feedback on LH is context-dependent and this is a classic Step 1 trap. At low to moderate levels (most of the cycle), estrogen exerts the expected negative feedback — it suppresses GnRH and LH. But when estrogen rises to a high sustained level for ~36 hours (just before ovulation), it switches to positive feedback on the pituitary, triggering the massive LH surge that causes follicle rupture and ovulation. If you apply only negative feedback logic, you cannot explain the LH surge at all — and the exam will absolutely test whether you can.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the full GnRH → LH/FSH → gonad → sex steroid cascade, including how feedback differs between baseline (negative) and the mid-cycle LH surge (positive feedback from sustained high estrogen).
  2. Understand why pulsatile GnRH maintains gonadotropin secretion while continuous GnRH — and GnRH agonist drugs like leuprolide — paradoxically suppress LH and FSH through receptor downregulation on pituitary gonadotrophs.
  3. Recognize that hyperprolactinemia causes secondary hypogonadism by suppressing hypothalamic GnRH pulsatility, not by directly inhibiting the ovaries or testes — and use this to correctly classify the level of axis disruption.

Can you avoid these mistakes?

A 45-year-old man with metastatic prostate cancer is started on leuprolide. Two weeks later his testosterone is undetectable. His friend, also on leuprolide, told him it 'turns on' the pituitary. Who is right, and what is the mechanism that explains the testosterone suppression?
A 28-year-old woman presents with amenorrhea, galactorrhea, and low libido. Labs show elevated prolactin, low LH, low FSH, and low estradiol. At what level of the HPG axis is the primary defect, and why?
During a normal menstrual cycle, estrogen levels peak just before ovulation. How does estrogen feedback differ at this point compared to the early follicular phase, and what is the physiological consequence?
You are comparing two GnRH treatment protocols in a research study: one delivers GnRH in 90-minute pulses, the other delivers it as a constant infusion. Predict the LH and FSH levels in each group after two weeks, and explain the receptor-level mechanism responsible for the difference.

Related topics

Hypothalamic-Pituitary-Adrenal (HPA) Axis Hypothalamic-Pituitary-Thyroid (HPT) Axis Hormone Signaling (Peptide vs Steroid) Prolactinoma

See how your Anki deck covers this topic.

Upload your deck for a free audit →